Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hematopoietic growth factor mimetics.

K Kaushansky1

  • 1Division of Hematology, University of Washington School of Medicine, Seattle, Washington 98195, USA. kkaushan@u.washington.edu

Annals of the New York Academy of Sciences
|July 19, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The JAK2V617F-bearing vascular niche promotes clonal expansion in myeloproliferative neoplasms.

Leukemia·2017
Same author

JAK2<sup>V617F</sup>-mutant megakaryocytes contribute to hematopoietic stem/progenitor cell expansion in a model of murine myeloproliferation.

Leukemia·2016
Same author

Megakaryocytes their precursors and their progeny.

Trends in cardiovascular medicine·2011
Same author

Molecular mechanisms of thrombopoietin signaling.

Journal of thrombosis and haemostasis : JTH·2009
Same author

Thrombopoietin: a tool for understanding thrombopoiesis.

Journal of thrombosis and haemostasis : JTH·2003
Same author

Mpl and the hematopoietic stem cell.

Leukemia·2002
Same journal

Multiomics Profiling During Autoimmune Demyelination Highlights a Complex Regulatory Role for Ataxin-1 in B Cells.

Annals of the New York Academy of Sciences·2026
Same journal

Global Trends in Light Pollution and Their Relationship With Socioeconomic Factors.

Annals of the New York Academy of Sciences·2026
Same journal

Wired for Corruption: Inter-Brain Synchrony Encodes Bribery-Related Value Information and Predicts Bribery Agreement.

Annals of the New York Academy of Sciences·2026
Same journal

LM-YOLO: A Lightweight Multi-Scale Enhanced Model for Forest Smoke Detection Using Unmanned Aerial Vehicles.

Annals of the New York Academy of Sciences·2026
Same journal

Polyrhythm Perception and Production: A Scoping Review.

Annals of the New York Academy of Sciences·2026
Same journal

DARTS-CNN-BiLSTM: Intelligent Fault Diagnosis for Computer Numerical Control Machine Tool Feed System.

Annals of the New York Academy of Sciences·2026
See all related articles

Researchers are developing small molecule drugs that mimic hematopoietic growth factors. These alternatives to expensive protein therapies offer potential for improved treatment and reduced immune responses in blood disorders.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Hematopoietic growth factors are large glycoproteins crucial for blood cell development.
  • Current recombinant protein therapies are costly, require injections, and can cause immune reactions.
  • Small molecule mimetics offer a promising alternative to protein-based growth factors.

Purpose of the Study:

  • To review strategies for identifying small molecule mimetics of hematopoietic growth factors.
  • To highlight successes in developing mimetics and antagonists for key growth factors.
  • To explore structural insights into growth factor-receptor interactions.

Main Methods:

  • High-throughput screening of large chemical and peptide libraries.
  • Utilizing biological function and receptor binding assays.

Related Experiment Videos

  • Structural studies of mimetic-receptor complexes.

    • Main Results:

    • Successful identification of small molecule mimetics and antagonists for erythropoietin, G-CSF, and thrombopoietin.
    • Demonstrated feasibility of screening vast compound libraries for therapeutic leads.
    • Elucidation of molecular mechanisms in growth factor-induced receptor activation.

    Conclusions:

    • Small molecule mimetics represent a viable and potentially superior alternative to protein-based hematopoietic growth factors.
    • Structural biology provides critical insights into signal transduction pathways.
    • This approach holds promise for developing novel treatments for hematological conditions.